pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Ultiva
drug
save

remifentanil hydrochloride

Marketedupdated 3mo ago
by Mylan Institutional Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • drugULTIVA69 co-mentions · 18 sources
  • tagApproval68 co-mentions · 17 sources
  • companyMylan Institutional Inc35 co-mentions · 18 sources
  • tagDrug Shortage1 co-mentions · 1 sources

all catalysts(17)

approval · 17
Jul 12, 1996
approval
30y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 23, 1999
approval
27y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 15, 1999
approval
27y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Nov 23, 1999
approval
27y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Sep 19, 2000
approval
26y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Nov 19, 2001
approval
25y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 3, 2002
approval
24y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 20, 2002
approval
24y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Mar 8, 2004
approval
22y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 11, 2013
approval
13y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jan 12, 2016
approval
11y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 16, 2016
approval
10y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 21, 2018
approval
8y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 7, 2019
approval
7y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 15, 2023
approval
3y ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 22, 2025
approval
8mo ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 22, 2025
approval
8mo ago
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
view all 17 catalysts →

Trials studying remifentanil hydrochloride

  • phase3BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babiesrecruitingn=6,000
  • phase2A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adultscompletedn=1,363
  • phase2A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)recruitingn=120
  • phase2Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infantscompletedn=1,208
  • phase2Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participantscompletedn=1,380
  • phase3Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infantsactive not recruitingn=1,800
  • phase1A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adultscompletedn=90
  • phase2Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Womencompletedn=306
more trials →

News(0)

no news has mentioned this drug yet

brand
Ultiva
generic
remifentanil hydrochloride
indication
Pain
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 27m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?